Ardent Health Reaffirms FY26 Adj EBITDA Guidance Of $485M-$535M
Commenting on the Company's financial outlook, Alfred Lumsdaine, Chief Financial Officer, said "During the second quarter, we've observed volume softness across our portfolio. We have taken appropriate and decisive
